title: Decreased expression of ferroportin in prostate cancer.
abstract: The present study examined the expression levels of ferroportin, a transmembrane protein that transports iron from the inside of a cell to the outside, in the prostate cancer PC3, DU145 and LNCAP cell lines, in the normal prostate RWPE2 cell line, and in tissue samples from different differentiation stages of prostatic carcinoma and prostatic hyperplasia. The study also investigated the role of ferroportin protein expression in the diagnosis and prognosis of prostate cancer. Reverse transcription-quantitative polymerase chain reaction and western blot analysis were employed to measure the mRNA and protein expression levels of ferroportin in the PC3, DU145, LNCAP and RWPE2 cells. Immunohistochemistry was used to determine ferroportin protein expression in the prostate cancer and prostatic hyperplasia tissues. Compared with the normal prostate RWPE2 cells, ferroportin protein expression was significantly lower in the prostate cancer PC3, DU145 and LNCAP cells (P<0.05). Compared with the prostatic hyperplasia tissues, ferroportin protein expression was significantly reduced in the prostate cancer tissues (P<0.05). Overall, the expression levels of ferroportin in the prostate cancer tissues were lower than those in the normal prostate tissues, which may provide valuable clinical information for the diagnosis and prediction of disease progression in prostate cancer, and may indicate a potential therapeutic target for treating prostate cancer by regulating iron metabolism.
authors.affiliation: Department of Urology, Third Affiliated Hospital, Suzhou University, Changzhou, Jiangsu 213003, P.R. China.
authors.forename: Dong
authors.initials: D
authors.lastname: Xue
authors.affiliation: Department of Urology, Third Affiliated Hospital, Suzhou University, Changzhou, Jiangsu 213003, P.R. China.
authors.forename: Cui-Xing
authors.initials: CX
authors.lastname: Zhou
authors.affiliation: Foreign Languages School, Changzhou Institute of Technology, Changzhou, Jiangsu 213002, P.R. China.
authors.forename: Yun-Bo
authors.initials: YB
authors.lastname: Shi
authors.affiliation: Department of Urology, Third Affiliated Hospital, Suzhou University, Changzhou, Jiangsu 213003, P.R. China.
authors.forename: Hao
authors.initials: H
authors.lastname: Lu
authors.affiliation: Department of Urology, Third Affiliated Hospital, Suzhou University, Changzhou, Jiangsu 213003, P.R. China.
authors.forename: Xiao-Zhou
authors.initials: XZ
authors.lastname: He
keywords: benign prostatic hyperplasia; ferroportin; hepcidin; prostate cancer